<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE us-patent-grant SYSTEM "us-patent-grant-v42-2006-08-23.dtd" [ ]>
<us-patent-grant lang="EN" dtd-version="v4.2 2006-08-23" file="US07642233-20100105.XML" status="PRODUCTION" id="us-patent-grant" country="US" date-produced="20091221" date-publ="20100105">
<us-bibliographic-data-grant>
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07642233</doc-number>
<kind>B2</kind>
<date>20100105</date>
</document-id>
</publication-reference>
<application-reference appl-type="utility">
<document-id>
<country>US</country>
<doc-number>11685986</doc-number>
<date>20070314</date>
</document-id>
</application-reference>
<us-application-series-code>11</us-application-series-code>
<classifications-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>C</section>
<class>07</class>
<subclass>K</subclass>
<main-group>14</main-group>
<subgroup>00</subgroup>
<symbol-position>F</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20100105</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
</classifications-ipcr>
<classification-national>
<country>US</country>
<main-classification>514  6</main-classification>
<further-classification>530385</further-classification>
</classification-national>
<invention-title id="d0e43">Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein</invention-title>
<references-cited>
<citation>
<patcit num="00001">
<document-id>
<country>US</country>
<doc-number>5028588</doc-number>
<kind>A</kind>
<name>Hoffman et al.</name>
<date>19910700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>514  6</main-classification></classification-national>
</citation>
<citation>
<patcit num="00002">
<document-id>
<country>US</country>
<doc-number>5239061</doc-number>
<kind>A</kind>
<name>Fronticelli et al.</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>530385</main-classification></classification-national>
</citation>
<citation>
<patcit num="00003">
<document-id>
<country>US</country>
<doc-number>5240831</doc-number>
<kind>A</kind>
<name>Barnes</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435 691</main-classification></classification-national>
</citation>
<citation>
<patcit num="00004">
<document-id>
<country>US</country>
<doc-number>5286638</doc-number>
<kind>A</kind>
<name>Tanaka et al.</name>
<date>19940200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435192</main-classification></classification-national>
</citation>
<citation>
<patcit num="00005">
<document-id>
<country>US</country>
<doc-number>5827693</doc-number>
<kind>A</kind>
<name>De Angelo et al.</name>
<date>19981000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435 696</main-classification></classification-national>
</citation>
<citation>
<patcit num="00006">
<document-id>
<country>US</country>
<doc-number>6022849</doc-number>
<kind>A</kind>
<name>Olson et al.</name>
<date>20000200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>514  6</main-classification></classification-national>
</citation>
<citation>
<patcit num="00007">
<document-id>
<country>US</country>
<doc-number>6114505</doc-number>
<kind>A</kind>
<name>Olson et al.</name>
<date>20000900</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>530385</main-classification></classification-national>
</citation>
<citation>
<patcit num="00008">
<document-id>
<country>US</country>
<doc-number>6172039</doc-number>
<kind>B1</kind>
<name>De Angelo et al.</name>
<date>20010100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>514  6</main-classification></classification-national>
</citation>
<citation>
<patcit num="00009">
<document-id>
<country>US</country>
<doc-number>6204009</doc-number>
<kind>B1</kind>
<name>Olson et al.</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435 691</main-classification></classification-national>
</citation>
<citation>
<patcit num="00010">
<document-id>
<country>US</country>
<doc-number>6455676</doc-number>
<kind>B1</kind>
<name>Weichert et al.</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>530385</main-classification></classification-national>
</citation>
<citation>
<patcit num="00011">
<document-id>
<country>US</country>
<doc-number>7019406</doc-number>
<kind>B2</kind>
<name>Huang et al.</name>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>257778</main-classification></classification-national>
</citation>
<citation>
<patcit num="00012">
<document-id>
<country>US</country>
<doc-number>7049406</doc-number>
<kind>B2</kind>
<name>Weickert et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>530385</main-classification></classification-national>
</citation>
<citation>
<patcit num="00013">
<document-id>
<country>US</country>
<doc-number>2005/0048479</doc-number>
<kind>A1</kind>
<name>Gandhi et al.</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435  6</main-classification></classification-national>
</citation>
<citation>
<patcit num="00014">
<document-id>
<country>US</country>
<doc-number>2007/0154993</doc-number>
<kind>A1</kind>
<name>Olson et al.</name>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435 696</main-classification></classification-national>
</citation>
<citation>
<patcit num="00015">
<document-id>
<country>US</country>
<doc-number>2007/0166792</doc-number>
<kind>A1</kind>
<name>Olson et al.</name>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>435 691</main-classification></classification-national>
</citation>
<citation>
<patcit num="00016">
<document-id>
<country>WO</country>
<doc-number>96/41885</doc-number>
<date>19961200</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00017">
<othercit>Thunell et al. 2000. Porphyrins, porphyrin metabolism, and porphyrias. I. Update. Scand J Clin Lab Invest. 60:509-540.</othercit>
</nplcit>
<category>cited by examiner</category>
</citation>
<citation>
<nplcit num="00018">
<othercit>McGovern, P. et al., (1976) J Biol Chem 251, 7871-7879.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00019">
<othercit>Ip, S. H. et al., (1976) Biochemistry 15, pp. 654-660.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00020">
<othercit>O'Malley, S. M. et al., (1994) J Protein Chem 13, pp. 585-590.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00021">
<othercit>Wycuff, D. R. and Matthews, K. S., Generation of an AraC-araBAD Promoter-Regulated T7 Expression System (2000) Anal. Biochem. 277, pp. 67-73.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00022">
<othercit>Kihm et al., An Abundant Erythroid Portien That Stabilizes Free Alpha-Hemoglobin, Nature 13, vol. 417, pp. 758-763, Jun. 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00023">
<othercit>Gell, D. et al., (2002) J Biol Chem 277, 40602-40609.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00024">
<othercit>Luzzatto, L. et al., (2002) Nature 417, pp. 703-705.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00025">
<othercit>Kong, Y. et al. (2004) J Clin. Invest.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00026">
<othercit>Santiveri, C. M. et al., (2004) J Biol Chem.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00027">
<othercit>Baudin-Creuza, v. et al., (2004) J Biol Chem.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00028">
<othercit>dos Santos, C.O. et al., (2004) Exp Hematol 32, pp. 157-162.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00029">
<othercit>Feng et al., Molecular Mechanism Of AHSP-Mediated Stabilization Of &#x3b2;&#x2014;Hemoglobin, Cell, vol. 119, 629-640, 12 pages, Nov. 24, 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00030">
<othercit>Feng et al., Structure of Oxidized &#x3b2;&#x2014;Haemoglobin Bound To AHSP Reveals a Protective Mechanism for Haem, Nature Publishing Group, vol. 435, pp. 697-701, Jun. 2, 2005.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00031">
<othercit>International Search Report and Written Opinion, PCT/US05/33028, 11 pages, Oct. 3, 2006.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00032">
<othercit>U.S. Appl. No. 60/610,109, filed Sep. 15, 2004, Olson et al.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00033">
<othercit>U.S. Appl. No. 60/610,108, filed Sep. 15, 2004, Olson et al.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00034">
<othercit>Abbasi et al. &#x201c;The Primary Structure of Sperm Whale Hemoglobin (<i>Physeter catodon</i>, Cetacea)&#x201d; Biol. Chem Hoppe-Seyler, vol. 367 (pp. 355-361), Apr. 1986.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00035">
<othercit>Ackers &#x201c;Deciphering The Molecular Code Of Hemoglobin Allostery&#x201d; Dept. Of Biochemistry and Biophysics, Washington University (pp. 185-253), 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00036">
<othercit>Ackers &#x201c;Energetics Of Subunit Assembly And Ligand Binding In Human Hemoglobin&#x201d; Dept. of Biology and McCollum Pratt Institute, The Johns Hopkins University (pp. 331-346), 1980.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00037">
<othercit>Adachi et al. &#x201c;Assembly of &#x3b3;- with &#x3b1;-Globin Chains to Form Human Fetal Hemoglobin in Vitro and in Vivo&#x201d; J Biol Chem, vol. 275, Issue 17 (16 pages), Apr. 28, 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00038">
<othercit>Adachi et al. &#x201c;Consequence of &#x3b2;16 and &#x3b2;112 Replacements on the Kinetics of Hemoglobin Assembly&#x201d; Biochemical and Biophysical Research Communications, vol. 289 (pp. 75-79), 2001.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00039">
<othercit>Adachi et al. &#x201c;Significance of &#x3b2;16 His (G18) at &#x3b1;1&#x3b2;1 Contact Sites for &#x3b1;&#x3b2; Assembly and Autoxidation of Hemoglobin&#x201d; Biochemistry, vol. 42 (pp. 10252-10259), Apr. 16, 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00040">
<othercit>Andrews et al. &#x201c;Bacterial iron homeostasis&#x201d; FEMS Microbiology Review 27 (pp. 215-237), 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00041">
<othercit>Antonini, E. and Brunori M., &#x201c;Hemoglobin and Myoglobin in Their Reactions with Ligands&#x201d;, North-Holland Publishing Company, Amsterdam, London, 1971, (pp. 110-119, 126-129).</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00042">
<othercit>Ascoli et al. &#x201c;Preparation and Properties of Apohemoglobin and Reconstituted Hemoglobins&#x201d; Methods in Enzymology, vol. 76 (pp. 72-87), 1981.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00043">
<othercit>Bagg et al. &#x201c;Ferric Uptake Regulation Protein Acts as a Repressor, Employing Iron (II) as a Cofactor To Bind the Operator of an Iron Transport Operon in <i>Escherichia coli</i>&#x201d; Biochemistry, vol. 26 (pp. 5471-5477), 1987.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00044">
<othercit>Barrick et al. &#x201c;Three-State Analysis of Sperm Whale Apomyoglobin Folding&#x201d; Biochemistry, vol. 32 (pp. 3790-3796), Feb. 1, 1993.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00045">
<othercit>Benesch et al. &#x201c;The Stability of the Heme-Globin Linkage in Some Normal, Mutant, and Chemically Modified Hemoglobins&#x201d; The Journal of Biological Chemistry, vol. 265, No. 25 (pp. 14881-14885), Feb. 9, 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00046">
<othercit>Bunn et al. &#x201c;Exchange of Heme among Hemoglobins and between Hemoglobin and Albumin&#x201d; The Journal of Biological Chemistry, vol. 243, No. 3 (pp. 465-475), Jun. 19, 1967.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00047">
<othercit>Bunn et al. &#x201c;Electrostatic interactions in the assembly of haemoglobin&#x201d; Nature 306 (pp. 498-500), Dec. 1983.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00048">
<othercit>Bunn, H.F. and Forget B.G., &#x201c;Hemoglobin: Molecular, Genetic and Clinical Aspects&#x201d;, W.B. Saunders Company, Philadelphia, 1986, (pp. 68-75).</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00049">
<othercit>Chu et al. &#x201c;Interaction of Human Apohemoglobin with Inositol Hexaphosphate&#x201d; The Journal of Biological Chemistry, vol. 254, No. 2 (pp. 371-376), Jan. 25, 1979.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00050">
<othercit>Daskaleros et al. &#x201c;Iron Uptake in <i>Plesiomonas shigelloides</i>: Cloning of the Genes for the Heme-Iron Uptake System&#x201d; Infection and Immunity, vol. 59, No. 8 (pp. 2706-2711), Aug. 1991.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00051">
<othercit>Dodson et al. &#x201c;Apomyoglobin as a molecular recognition surface: expression, reconstitution and crystallization of recombinant porcine myoglobin in <i>Excherichia coli</i>&#x201d; Protein Engineering vol. 2, No. 3 (pp. 233-237), 1988.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00052">
<othercit>Dou et al. &#x201c;Myoglobin as a model system for designing heme protein based blood substitutes&#x201d; Biophysical Chemistry 98 (pp. 127-148), 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00053">
<othercit>Dumoulin et al. &#x201c;The N-terminal Sequence Affects Distant Helix Interactions in Hemoglobin&#x201d; The Journal of Biological Chemistry, vol. 273, No. 52 (pp. 35032-35038), Dec. 25, 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00054">
<othercit>Edelstein &#x201c;Cooperative Interactions of Hemoglobin&#x201d; Annu Review Biochem 44 (pp. 209-232), 1975.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00055">
<othercit>Eliezer et al. &#x201c;Native and Non-native Secondary Structure and Dynamics in the pH 4 Intermediate of Apomyoglobin&#x201d; Biochemistry 39 (pp. 2894-2901), Jan. 7, 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00056">
<othercit>Eliezer et al. &#x201c;Populating the equilibrium molten globule state of apomyoglobin under conditions suitable for structural characterization by NMR&#x201d; Federation of European Biochemical Sciences Letter 417 (pp. 92-96), Sep. 11, 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00057">
<othercit>Eliezer et al. &#x201c;Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding&#x201d; Nature Structural Biology 5 (pp. 148-155), Feb. 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00058">
<othercit>Fronticelli et al. &#x201c;Alloseric Modulation by Tertiary Structure in Mammalian Hemoglobins&#x201d; The Journal of Biological Chemistry, vol. 270, No. 51 (pp. 30588-30592), Dec. 22, 1995.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00059">
<othercit>Garcia et al. &#x201c;Changes in Apomyoglobin Folding Pathway Caused by Mutation of the Distal Histidine Residue&#x201d; Biochemistry 39 (pp. 11227-11237), 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00060">
<othercit>Gattoni et al. &#x201c;Stability of the Heme-Globin Linkage in &#x3b1;&#x3b2; Dimers and Isolated Chains of Human Hemoglobin&#x201d; The Journal of Biological Chemistry, vol. 271, No. 17 (pp. 10130-10136). Apr. 26, 1996.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00061">
<othercit>Genco et al. &#x201c;Emerging strategies in microbial haem capture&#x201d; Molecular Microbiology, vol. 39 (pp. 1-11), 2001.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00062">
<othercit>Ghigo et al. &#x201c;A New Type of Hemophore-Dependent Heme Acquisition System of <i>Serratia marcescens </i>Reconstituted in <i>Escherichia coli</i>&#x201d; Journal of Bacteriology, vol. 179, No. 11 (pp. 3572- 3579), Jun. 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00063">
<othercit>Gibson et al. &#x201c;Kinetic Studies on the Reaction between Native Globin and Haem Derivatives&#x201d; Biochem J 77 (pp. 328-341), 1960.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00064">
<othercit>Gibson et al. &#x201c;Rates of Reaction of Native Human Globin with Some Hemes&#x201d; The Journal of Biological Chemistry, vol. 258, No. 4 (pp. 1384-1388), Apr. 1963.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00065">
<othercit>Griggs et al. &#x201c;Mechanism for Iron-Related Transcription of the <i>Escherichia coli cir </i>Gene: Metal-Dependent Binding of Fur Protein to the Promoters&#x201d; Journal of Bacteriology, vol. 171, No. 2 (pp. 1048-1054), Feb. 1989.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00066">
<othercit>Hargrove et al. &#x201c;Stability of Myoglobin: A Model for the Folding of Heme Proteins&#x201d; Biochemistry 33 (pp. 11767-11775), Jun. 14, 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00067">
<othercit>Hargrove et al. &#x201c;The Association Rate Constant for Heme Binding to Globin is Independent of Protein Structure&#x201d; Biochemistry 35 (pp. 11293-11299), 1996.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00068">
<othercit>Hargrove et al. &#x201c;The Stability of Holomyoglobin is Determined by Heme Affinity&#x201d; Biochemistry 35 (pp. 11310-11318), 1996.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00069">
<othercit>Hargrove et al. &#x201c;Quaternary Structure Regulates Hemin Dissociation from Human Hemoglobin&#x201d; Journal of Biololgical Chemistry vol. 272, No. 28 (pp. 17385-17389), 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00070">
<othercit>Henderson et al. &#x201c;Characterization of the <i>Plesiomonas shigelloides </i>Genes Encoding the Heme Iron Utilization System&#x201d; Journal of Bacteriology, vol. 183, No. 9 (pp. 2715-2723), May 2001.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00071">
<othercit>Henderson et al. &#x201c;Characterization of the <i>Vibrio cholerae </i>Outer Membrane Heme Transport Protein HutA: Sequence of the Gene, Regulation of Expression, and Homology to the Family of TonB- Dependent Proteins&#x201d; Journal of Bacteriology, vol. 176, No. 11 (pp. 3269-3277), Jun. 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00072">
<othercit>Henderson et al. &#x201c;Cloning and characterization of the <i>Vibrio cholerae </i>genes encoding the utilization of iron from haemin and haemoglobin&#x201d; Molecular Microbiology, vol. 7 (pp. 461-469), 1993.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00073">
<othercit>Henderson et al. &#x201c;<i>Vibrio cholerae </i>Iron Transport Systems: Roles of Heme and Siderophore Iron Transport in Virulence and Identification of a Gene Associated with Multiple Iron Transport Systems&#x201d; Infection and Immunity, vol. 62, No. 11 (pp. 5120-5125), Nov. 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00074">
<othercit>Hughson et al. &#x201c;Structural Characterization of a Partly Folded Apomyoglubin Intermediate&#x201d; Science vol. 249 (pp. 1544-1548), 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00075">
<othercit>International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2005/032627 (5 pages), Mar. 29, 2007.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00076">
<othercit>International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2005/033027 (6 pages), Mar. 29, 2007.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00077">
<othercit>International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2005/033028 (6 pages), Mar. 29, 2007.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00078">
<othercit>International Search Report and Written Opinion for International Application No. PCT/US2005/032627 (8 pages), Mar. 14, 2006.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00079">
<othercit>International Search Report and Written Opinion for International Application No. PCT/US2005/033027 (9 pages), Nov. 1, 2006.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00080">
<othercit>International Search Report and Written Opinion for International Application No. PCT/US2005/033028 (11 pages), Oct. 3, 2006.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00081">
<othercit>Ip et al. &#x201c;Kinetics of Deoxyhemoglobin Subunit Dissociation Determined by Haptoglobin Binding: Estimation of the Equilibrium Constant from Forward and Reverse Rates&#x201d; Biochemistry vol. 15, No. 3 (pp. 654-660), 1976.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00082">
<othercit>Ip et al. &#x201c;Thermodynamic Studies on Subunit Assembly in Human Hemoglobin&#x201d; The Journal of Biological Chemistry vol. 252, No. 1 (pp. 82-87), 1977.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00083">
<othercit>Jennings et al. &#x201c;Esterification of the Propionate Groups Promotes &#x3b1; / &#x3b2; Hemoglobin Chain Homogeneity of CN-hemin Binding&#x201d; Biochemical and Biophysical Research Communications 293 (pp. 1354-1357), 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00084">
<othercit>Joshi, J &#x201c;Role of &#x3b1; and &#x3b2; Carboxyl-terminal Residues in the Kinetics of Human Oxyhemoglobin Dimer Assembly&#x201d; The Journal of Biological Chemisstry, vol. 269, No. 11 (pp. 8549-8553), 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00085">
<othercit>Kooyman et al. &#x201c;The Physiological Basis of Diving to Depth: birds and Mammals&#x201d; Annu. Rev. Physiol., vol. 60 (pp. 19-32), 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00086">
<othercit>Kowalczyck et al. &#x201c;Dimensions in Solution of Pyridoxylated Apohemoglobin&#x201d; Biochemistry 22 (pp. 4805-4809), 1983.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00087">
<othercit>L&#xe9;toff&#xe9; et al. &#x201c;Free and Hemophore-Bound Heme Acquisitions through the Outer Membrane Receptor HasR Have Different Requirements for the TonB-ExbB-ExBD Complex&#x201d; Journal of Bacteriology, vol. 186, No. 13 (pp. 4067-4074), Jul. 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00088">
<othercit>Light et al. &#x201c;The Effects of Lipid Composition on the Rate and Extent of Heme Binding to Membranes&#x201d; The Journal of Biological Chemistry, vol. 265, No. 26 (pp. 15632-15637), 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00089">
<othercit>Light et al. &#x201c;Transmembrane Movement of Heme&#x201d; The Journal of Biological Chemistry, vol. 265, No. 26 (pp. 15623-15631), 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00090">
<othercit>Litwin et al. &#x201c;Role of Iron in Regulation of Virulence Genes&#x201d; Clinical Microbiology Reviews, vol. 6, No. 2 (pp. 137-149), Apr. 1993.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00091">
<othercit>Lloyd et al. &#x201c;Formation of Sulphmyoglobin During Expression of Horse Heart Myoglobin in <i>Escherichia coli</i>&#x201d; Federation of European Biochemical Societies Letters 340 (pp. 281-286), 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00092">
<othercit>Looker et al. &#x201c;Expression of Recombinant Human Hemoglobin in<i>Escherichia coli </i>&#x201d; Methods in Enzymology, vol. 231 (pp. 364-374), 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00093">
<othercit>McDonald et al. &#x201c;Structural, Functional, and Subunit Assembly Properties of Hemoglobin Attleboro [&#x3b1;138 (H21) Ser &#x2192; Pro], a Variant Possessing a Site Mutation at a Critical C-Terminal Residue&#x201d; Biochemistry 29 (pp. 173-178), 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00094">
<othercit>McDonald et al. &#x201c;The Kinetics of Assembly of Normal and Variant Human Oxyhemoglobins&#x201d; The Journal of Biological Chemistry, vol. 262, No. 13 (pp. 5951-5956), 1987.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00095">
<othercit>McDonald et al. &#x201c;Subunit Assembly of Normal and Variant Human Hemoglobins&#x201d; the Red Cell: Sixth Ann Arbor Conference 1984 (pp. 2-11).</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00096">
<othercit>McGovern et al. &#x201c;Aggregation of Deoxyhemoglobin Subunits&#x201d; The Journal of Biological Chemistry, vol. 251 (pp. 7871-7879).</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00097">
<othercit>Mills et al. &#x201c;Genetics and Regulation of Heme Iron Transport in <i>Shigella dysenteriae </i>and Detection of an Analogous System in <i>Escherichia coli </i> O157:H7&#x201d; Journal of Bacteriology, vol. 177, No. 11 (pp. 3004-3009) Jun. 1995.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00098">
<othercit>Moulton et al. &#x201c;Kinetics of Human Apohemoglobin Dimer Dissociation&#x201d; Biochemical and Biophysical Research Communications, vol. 199, No. 3 (pp. 1278-1283), 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00099">
<othercit>Mourino et al. &#x201c;Characterization of Heme Uptake Cluster Genes in the Fish Pathogen Vibrio anguillarum&#x201d; J Bacteriol. vol. 186, No. 18 (1 page), Sep. 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00100">
<othercit>Mrabet et al. &#x201c;Dissociation of Dimers of Human Hemoglobins A and F into Monomers&#x201d; The Journal of Biological Chemictry, vol. 261, No. 3 (pp. 1111-1115), 1984.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00101">
<othercit>Mrabet et al. &#x201c;Electrostatic Attraction Governs the Dimer Assembly of Human Hemoglobin&#x201d; The Journal of Biological Chemistry, vol. 261, No. 11 (pp. 5222-5228), 1986.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00102">
<othercit>Musto et al. &#x201c;Folding of <i>Aplysia limacina </i>Apomyoglobin Involves an Intermediate in Common with Other Evolutionarily Distant Globins&#x201d; Biochemistry 43 (pp. 230-236), 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00103">
<othercit>Nishimura et al. &#x201c;Role of the B Helix in Early Folding Events in Apomyoglobin: Evidence from Site-directed Mutagenesis for Native-like Long Range Interactions&#x201d; J Mol Biol 334 (pp. 293-307), 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00104">
<othercit>Nishimura et al. &#x201c;Conservation of Folding Pathways in Evolutionarily Distant Globin Sequences&#x201d; Nature Structure Biology, vol. 7, No. 8 (pp. 679-686), 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00105">
<othercit>Olson et al. &#x201c;Protein Engineering Strategies For Designing More Stable Hemoglobin-Based Blood Substitutes&#x201d; Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 25 (pp. 227-241), 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00106">
<othercit>Olson et al. &#x201c;No Scavenging and the Hypertensive Effect of Hemoglobin-based Blood Substitutes&#x201d; Free Radical Biology &#x26; Medicine, vol. 36, No. 6 (pp. 685-697), 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00107">
<othercit>O'Malley et al. &#x201c;Monitoring the Effect of Subunit Assembly on the Structural Flexibility of Human Alpha Apohemoglobin by Steady-State Fluorescence&#x201d; The Journal of Protein Chemistry, vol. 13, No. 6 (pp. 561-567), 1994.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00108">
<othercit>Oton et al. &#x201c;Fluorescence Studies of Internal Rotation in Apohemoglobin &#x3b1;-Chains&#x201d; Archives of Biochemistry Biophysics, vol. 228, No. 2 (pp. 519-524), Feb. 1, 1984.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00109">
<othercit>Paquelin et al. &#x201c;Characterization of HasB, a <i>Serratia marcescens </i>TonB-like protein specifically involved in the haemophore -dependent haem acquisition system&#x201d; Molecular Microbiology, vol. 42, No. 4 (pp. 995-1005), 2001.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00110">
<othercit>Perutz. &#x201c;Mechanisms Regulating the Reactions of Human Hemoglobin with Oxygen and Carbon Monoxide&#x201d; Annual Review of Physiology 52 (pp. 1-25), 1990.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00111">
<othercit>Perutz &#x201c;Stereochemistry of Cooperative Effects in Haemoglobin&#x201d; Nature, vol. 228 (pp. 726-739), Nov. 21, 1970.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00112">
<othercit>Pohl et al. &#x201c;Architecture of a protein central to iron homeostasis: crystal structure and spectroscopic analysis of the ferric uptake regulator&#x201d; Molecular Microbiology, vol. 47 (pp. 903-915), 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00113">
<othercit>Postle et al. &#x201c;Touch and go: tying TonB to transport&#x201d; Molecular Microbiology, vol. 49 (pp. 869-882), 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00114">
<othercit>Ramsay et al. &#x201c;Modified Spectrophotometer for Multi-Dimensional Circular Dichroism/Fluoresence Data Acquisition in Titration Experiments: Application to the pH and Guanidine-HCI Induced Unfolding of Apomyoglobin&#x201d; Biophysical Journal, vol. 69 (pp. 701-707), Aug. 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00115">
<othercit>Reeves et al. &#x201c;TonB Is Required for Intracellular Growth and Virulence of <i>Shigella dysenteriae </i>&#x201d; Infection and Immunity, vol. 68, No. 11 (pp. 6329-6336), Nov. 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00116">
<othercit>Rose et al. &#x201c;The Kinetic Mechanism of Heme Binding to Human Apohemoglobin&#x201d; The Journal of Biological Chemistry, vol. 258, No. 7 (pp. 4298-4303), Apr. 10, 1983.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00117">
<othercit>Sassaroli et al. &#x201c;Specialized Functional Domains in Hemoglobin: Dimensions in Solution of the Apohemoglobin Dimer Labeled with Fluorescein Iodoacetamide&#x201d; Biochemistry 23 (pp. 2487-2491), 1984.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00118">
<othercit>Scott et al. &#x201c;The Stabilities of Mammalian Apomyoglobins Vary over a 600-Fold Range and Can Be Enhanced by Comparative Mutagenesis&#x201d; The Journal of Biological Chemistry, vol. 275, No. 35 (pp. 27129-27136), Sep. 1, 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00119">
<othercit>Seliger et al. &#x201c;The two TonB systems of <i>Vibrio cholerae</i>: redundant and specific functions&#x201d; Molecular Microbiology, vol. 39 (pp. 801-812), 2001.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00120">
<othercit>Shaeffer et al. &#x201c;Dimer-Monomer Dissociation of Human Hemoglobin A&#x201d; The Journal of Biological Chemistry, vol. 259, No. 23 (pp. 14544-14547), Dec. 10, 1984.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00121">
<othercit>Shen et al. &#x201c;Production of human normal adult and fetal hemoglobins in <i>Escherichia coli</i>&#x201d; Protein Engineering, vol. 10 (1 page), 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00122">
<othercit>Smith, &#x201c;The Effects of Amino Acid Substitution on Apomyoglobin Stability, Folding Intermediates, and Holoprotein Expression&#x201d;, Ph.D. Dissertation, Biochemistry &#x26; Cell Biology, Rice University Houston Texas, 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00123">
<othercit>Snyder &#x201c;Respiratory Adaptions in Diving Mammals&#x201d; Respiration Physiology 54 (pp. 296-294), 1983.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00124">
<othercit>Springer et al. &#x201c;High-level expression of sperm whale myoglobin in <i>Escherichia coli</i>&#x201d; Proc. Natl. Acad. Sci., Vol. 84 (pp. 8961-8965), Dec. 1987.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00125">
<othercit>Stojiljkovic et al. &#x201c;Hemin uptake system of <i>Yersinia enterocolitica</i>: similarities with other TonB-dependent systems in Gram-negative bacteria&#x201d; The EMBO Journal, vol. 11, No. 12 (pp. 4359-4367), 1992.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00126">
<othercit>Stojiljkovic et al. &#x201c;Processing of Heme and Heme-Containing Proteins by Bacteria&#x201d; DNA and Cell Biology, vol. 21, No. 4 (pp. 281-295), 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00127">
<othercit>Tang et al. &#x201c;Disruption of the Heme Iron-Proximal Histidine Bond Requires Unfolding of Deoxymyoglobin&#x201d; Biochemistry 37 (pp. 7047-7056), Feb. 26, 1998.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00128">
<othercit>Thompson et al. &#x201c;Molecular Characterization of the Hemin Uptake Locus (<i>hmu</i>) from <i>Yersinia pestis </i>and Analysis of <i>hmu </i>Mutants for Hemin and Hemoprotein Utilization&#x201d; Infection and Immunity, vol. 67, No. 8 (pp. 3879-3892), Aug. 1999.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00129">
<othercit>Torres et al. &#x201c;Haem iron-transport system in enterohaemorrhagic <i>Escherichia coli </i>O157:H7&#x201d; Molecular Microbiology, vol. 23 (pp. 825-833), 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00130">
<othercit>Varadarajan et al. &#x201c;Cloning, expression in <i>Excherichia coli</i>, and reconstitution of human myoglobin&#x201d; Proc. Natl. Acad. Sci., vol. 82 (pp. 5681-5684), Sep. 1985.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00131">
<othercit>Vasudevan et al. &#x201c;Ordered Heme Binding Ensures the Assembly of Fully Functional Hemoglobin: A Hypothesis&#x201d; Current Protein and Peptide Science 3 (pp. 461-466), 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00132">
<othercit>Vasudevan et al. &#x201c;Spectral Demonstration of Semihemoglobin Formation during CN-Hemin Incorporation into Human Apohemoglobins&#x201d; The Journal of Biological Chemistry, vol. 272, No. 1 (pp. 517-524), Jan. 3, 1997.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00133">
<othercit>Vasudevan et al. &#x201c;Wavelength-Dependent Spectral Changes Accompany CN-Hemin Binding to Human Apohemoglobin&#x201d; Journal of Protein Chemistry, vol, 19, No. 7 (pp. 583-590), 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00134">
<othercit>Varnado et al. &#x201c;System for the expression of recombinant hemoproteins in <i>Escherichia coli</i>&#x201d; Protein Expression and Purification 35 (pp. 76-83), 2004.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00135">
<othercit>Villaloboz et al. &#x201c;0-083. Using <i>Escherichia coli </i>Containing the <i>Plesiomonas shigelloides </i>Heme Transport System to Increase the Production of Myoglobin&#x201d; Abstracts of the General Meeting of the American Society for Microbiology, vol. 103, Abstr 0-083; Issn: 1060-2011 (pg. 482), 2003.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00136">
<othercit>Volkmar et al. &#x201c;Iron transport and signaling in <i>Escherichia coli</i>&#x201d; FEBS Letters 529 (pp. 78-85), 2002.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00137">
<othercit>Waks et al. &#x201c;Influence of Prosthetic Groups on Protein Folding and Subunit Assembly&#x201d; The Journal of Biological Chemistry, vol. 248, No. 18 (pp. 6462-6470), Sep. 25, 1973.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00138">
<othercit>Wiedermann et al. &#x201c;Acceleration of Tetramer Formation by the Binding of Inositol Hexaphosphate to Hemoglobin Dimers&#x201d; The Journal of Biological Chemistry, vol. 250, No. 13 (pp. 5273-5275), Jul. 10, 1975.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00139">
<othercit>Yamaguchi et al. &#x201c;Surface and Interface &#x3b2;-Chain Residues Synergistically Affect Hemoglobin Assembly&#x201d; Biochemical and Biophysical Research Communications 270 (pp. 683-687), Mar. 7, 2000.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00140">
<othercit>Zapol et al. &#x201c;Regional blood flow during simulated diving in the conscious Weddell seal&#x201d; J Applied Physiol, the American Physiological Society 47 (pp. 968-973), 1979.</othercit>
</nplcit>
<category>cited by other</category>
</citation>
<citation>
<nplcit num="00141">
<othercit>Supplementary European Search Report for Application No. EP 05796424.9 dated Jan. 20, 2009 (6 pages).</othercit>
</nplcit>
<category>cited by other</category>
</citation>
</references-cited>
<number-of-claims>20</number-of-claims>
<us-exemplary-claim>1</us-exemplary-claim>
<us-field-of-classification-search>
<classification-national>
<country>US</country>
<main-classification>None</main-classification>
</classification-national>
</us-field-of-classification-search>
<figures>
<number-of-drawing-sheets>2</number-of-drawing-sheets>
<number-of-figures>3</number-of-figures>
</figures>
<us-related-documents>
<continuation>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>PCT/US2005/033028</doc-number>
<kind>00</kind>
<date>20050915</date>
</document-id>
<parent-status>PENDING</parent-status>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>11685986</doc-number>
</document-id>
</child-doc>
</relation>
</continuation>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60610108</doc-number>
<kind>00</kind>
<date>20040915</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60610109</doc-number>
<kind>00</kind>
<date>20040915</date>
</document-id>
</us-provisional-application>
<us-provisional-application>
<document-id>
<country>US</country>
<doc-number>60610110</doc-number>
<kind>00</kind>
<date>20040915</date>
</document-id>
</us-provisional-application>
<related-publication>
<document-id>
<country>US</country>
<doc-number>20070154993</doc-number>
<kind>A1</kind>
<date>20070705</date>
</document-id>
</related-publication>
</us-related-documents>
<parties>
<applicants>
<applicant sequence="001" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Olson</last-name>
<first-name>John S.</first-name>
<address>
<city>Houston</city>
<state>TX</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
<applicant sequence="002" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Weiss</last-name>
<first-name>Mitchell J.</first-name>
<address>
<city>Wynnewood</city>
<state>PA</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
</applicants>
<agents>
<agent sequence="01" rep-type="attorney">
<addressbook>
<orgname>Baker Botts L.L.P.</orgname>
<address>
<country>unknown</country>
</address>
</addressbook>
</agent>
</agents>
</parties>
<assignees>
<assignee>
<addressbook>
<orgname>William Marsh Rice University</orgname>
<role>02</role>
<address>
<city>Houston</city>
<state>TX</state>
<country>US</country>
</address>
</addressbook>
</assignee>
<assignee>
<addressbook>
<orgname>The Children's Hospital of Philadelphia</orgname>
<role>02</role>
<address>
<city>Philadelphia</city>
<state>PA</state>
<country>US</country>
</address>
</addressbook>
</assignee>
</assignees>
<examiners>
<primary-examiner>
<last-name>Carlson</last-name>
<first-name>Karen Cochrane</first-name>
<department>1656</department>
</primary-examiner>
</examiners>
</us-bibliographic-data-grant>
<abstract id="abstract">
<p id="p-0001" num="0000">The present disclosure relates to the use of AHSP to stabilize the &#x3b1; subunit of rHb. AHSP may be co-expressed with the hemoglobin genes. AHSP stabilization may be used to increase the production of intact rHb in various systems, such as <i>E. coli</i>, other microorganisms, or animal erythroid cells. This intact rHb may then be used as part of a blood substitute product.</p>
</abstract>
<drawings id="DRAWINGS">
<figure id="Fig-EMI-D00001" num="00001">
<img id="EMI-D00001" he="206.67mm" wi="158.75mm" file="US07642233-20100105-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00002" num="00002">
<img id="EMI-D00002" he="59.10mm" wi="148.84mm" file="US07642233-20100105-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
</drawings>
<description id="description">
<?RELAPP description="Other Patent Relations" end="lead"?>
<heading id="h-0001" level="1">RELATED APPLICATION</heading>
<p id="p-0002" num="0001">This application is a continuation of International Patent Application No. PCT/US2005/033028, filed on Sep. 15, 2005, which claims priority to U.S. Provisional Patent Application No. 60/610,108, filed on Sep. 15, 2004, U.S. Provisional Patent Application No. 60/610,109, filed on Sep. 15, 2004, and U.S. Provisional Patent Application No. 60/610,110, filed on Sep. 15, 2004, the full disclosures of which are incorporated herein by reference.</p>
<?RELAPP description="Other Patent Relations" end="tail"?>
<?BRFSUM description="Brief Summary" end="lead"?>
<heading id="h-0002" level="1">TECHNICAL FIELD</heading>
<p id="p-0003" num="0002">The present disclosure relates to compositions and/or methods of producing compositions that include a form of hemoglobin.</p>
<heading id="h-0003" level="1">BACKGROUND</heading>
<p id="p-0004" num="0003">Hemoglobin (Hb) is responsible for carrying and delivering oxygen to tissues and organs in animals and has been used in development of an effective and safe oxygen carrier as an alternative to blood transfusion. Hb can be obtained easily in large quantities from bovine sources, or can be produced transgenically, so the raw material is not limiting. Such forms of Hb, however, may have numerous serious side effects when transfused into a human patient. For example, raw Hb may cause vasoconstriction, abdominal pain, and acute kidney failure. In addition, products may cause elevation of blood pressure and other problems associated with interference with smooth muscle regulation.</p>
<p id="p-0005" num="0004">Some of these effects may stem from the toxicity of Hb when it is outside of a red blood cell (erythrocyte). In addition, Hb outside of a red blood cell is rapidly broken down from its tetrameric form into dimers and monomers. These products may be taken up by the kidney and impair nephrological functions. Production of hemoglobin (Hb) may be limited by the stability of the globin chains (protein without the heme bound), particularly the &#x3b1; subunits which are generally less stable than the partner &#x3b2; subunits.</p>
<heading id="h-0004" level="1">SUMMARY</heading>
<p id="p-0006" num="0005">Therefore, a need exists for oxygen delivery compositions that are safer, more clinically effective, and/or more economically produced. In addition, there is a need for compositions, systems, and methods for increasing the stability of hemoglobin (Hb) subunits (e.g., the &#x3b1; subunit). Improvements that lower production costs or decrease degradation products or otherwise provide a commercially applicable benefit are particularly needed, which may facilitate commercial production of Hb and/or provide additional benefits.</p>
<p id="p-0007" num="0006">The present disclosure, according to some example embodiments, relates to methods of producing hemoglobin comprising contacting the hemoglobin with an &#x3b1; hemoglobin stabilizing protein (e.g., a wild-type form, a derivative thereof, and a mutant thereof; collectively &#x201c;AHSP&#x201d;). For example, a nucleic acid encoding hemoglobin and a nucleic acid encoding AHSP may be co-expressed in a cell. According to some embodiments, AHSP stabilization may be used to increase the production of intact hemoglobin in various systems, such as <i>E. coli</i>, other microorganism, or animal erythroid cells. In some embodiments, hemoglobin so-produced may be used as or in a blood substitute.</p>
<p id="p-0008" num="0007">According to some embodiments, a hemoglobin subunit may be a wild-type or modified form of hemoglobin subunit from any species. For example, a wild-type or recombinant form of human hemoglobin may be used. In some specific example embodiments, human globin and human AHSP may be used. Both &#x3b1; and &#x3b2; globin and AHSP may all be expressed from transgenic nucleic acids in a single cell, such as an <i>E. coli </i>cell, other microorganisms, such a yeast or other bacteria, or an animal erythroid cell, particularly a mammalian erythroid cell. For example, plasmid vectors may be used to achieve co-expression.</p>
<p id="p-0009" num="0008">Additional example embodiments of the present disclosure include hemoglobin production cells, tissues, or animals in which AHSP is provided to stabilize a hemoglobin molecule, such as a hemoglobin. Other embodiments may relate to nucleic acids that encode AHSP and at least two different hemoglobin subunits for co-expression in the same cell to produce hemoglobin. Still other example embodiments relate to systems including cells, such as <i>E. coli </i>cells, other microorganisms, or animal erythroid cells, in which a hemoglobin or another hemoglobin is stabilized by AHSP. These systems may also exhibit increased hemoglobin production and fewer degradation products when compared with similar systems lacking AHSP. Other example embodiments relate to methods of making the above cells and nucleic acids, as well as to methods of producing recombinant hemoglobin by stabilizing &#x3b1; hemoglobin with AHSP.</p>
<?BRFSUM description="Brief Summary" end="tail"?>
<?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?>
<description-of-drawings>
<heading id="h-0005" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
<p id="p-0010" num="0009">The present disclosure may be better understood through reference to the following detailed description, taken in conjunction with the following figures in which:</p>
<p id="p-0011" num="0010"><figref idref="DRAWINGS">FIG. 1</figref> illustrates a simple scheme for hemoglobin assembly in both <i>E. coli</i>, other microorganisms, and erythroid cells.</p>
<p id="p-0012" num="0011"><figref idref="DRAWINGS">FIG. 2</figref> illustrates possible functions of AHSP in facilitating &#x3b1; chain folding and hemoglobin formation.</p>
<p id="p-0013" num="0012"><figref idref="DRAWINGS">FIG. 3</figref> illustrates enhanced expression of &#x3b1; globin in COS cells in the presence and absence of a proteosome inhibitor.</p>
</description-of-drawings>
<?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?>
<?DETDESC description="Detailed Description" end="lead"?>
<heading id="h-0006" level="1">DETAILED DESCRIPTION</heading>
<p id="p-0014" num="0013">The present disclosure, according to one example embodiment, relates to the use of AHSP to stabilize the &#x3b1; subunit of rHb. AHSP may be provided by any available means. For example, AHSP may be co-expressed with a hemoglobin gene in a cell. AHSP stabilization may be used to increase the production of intact rHb in various systems, such as <i>E. coli</i>, other microorganisms, such as yeast or other bacteria, or animal erythroid cells, particularly mammalian erythroid cells. This intact rHb may then be used as part of a blood substitute product.</p>
<p id="p-0015" num="0014">In specific example embodiments, human globin and human AHSP may be used. Both &#x3b1; and &#x3b2; globin and AHSP may all be expressed from transgenic nucleic acids in a single cell, such as an <i>E. coli </i>cell, other microorganisms, or an animal erythroid cell. For example, plasmid vectors may be used to achieve co-expression.</p>
<p id="p-0016" num="0015">Without being limited to any particular mechanism of action or theory, in some example embodiments, AHSP may facilitate folding of the &#x3b1; subunits and in turn facilitate their reaction with &#x3b2; subunits to form assembled hemoglobin dimers and tetramers. These dimers and tetramers, in some embodiments, may be much more stable and/or may rapidly bind heme. In some example embodiments of the present disclosure, the AHSP surface that interacts with &#x3b1; globin may be modified to stabilize other globin subunits and also to catalyze the assembly of almost any hemoglobin in bacteria. For example, it may be modified to stabilize the &#x3b2; globin subunit.</p>
<p id="p-0017" num="0016">Thus, some example embodiments of the present disclosure include rHb production cells, tissues, or animals, in which AHSP is provided to stabilize a hemoglobin molecule, such as &#x3b1; hemoglobin. Some example embodiments may relate to nucleic acids that encode AHSP and at least two different hemoglobin subunits for co-expression in the same cell to produce rHb. Some example embodiments relate to systems including microorganisms (e.g., <i>E. coli</i>) or animal erythroid cells, in which &#x3b1; hemoglobin or another hemoglobin is stabilized by AHSP. These systems may also exhibit increased rHb production and fewer degradation products when compared with similar systems lacking AHSP. Other embodiments relate to methods of making the above cells and nucleic acids as well as to methods of producing rHb by stabilizing &#x3b1; hemoglobin with AHSP.</p>
<p id="p-0018" num="0017">Certain embodiments of the present disclosure may be used in conjunction with existing rHb technologies. For example, it may be used in connection with U.S. provisional patent Nos. 60/610,109 and 60/610,108, as well as U.S. Pat. Nos. 6,455,676; 6,204,009; 6,114,505; 6,022,849; and U.S. patent application publication No. 2003 0017537 (all incorporated by reference herein).</p>
<p id="p-0019" num="0018">The following discussion relates to specific example embodiments of the disclosure.</p>
<p id="p-0020" num="0019">The assembly of hemoglobin in either bacterial or in animal erythroid cells is a complex process (<figref idref="DRAWINGS">FIG. 1</figref>) involving ribosomal synthesis of two different protein chains or subunits (&#x3b1;, 141 amino acids and &#x3b2;, 146 amino acids). The newly synthesized &#x3b1; and &#x3b2; subunits do not appear to have any well-formed structure in the absence of a partner, and first assemble to form an &#x3b1;<sub>1</sub>&#x3b2;<sub>1 </sub>dimer, which itself is very unstable (apo &#x3b1;<sub>1</sub>&#x3b2;<sub>1 </sub>dimer in <figref idref="DRAWINGS">FIG. 1</figref>, where the suffix apo means no heme is bound and the protein has no &#x201c;red&#x201d; color). Only after heme (iron containing red pigment) is bound is the protein stabilized and resistant to degradation and precipitation. Hemoglobin synthesis in bacteria is limited by the availability of heme, and as a result, newly formed &#x3b1; and &#x3b2; proteins that are unable to find heme tend to precipitate or be degraded by bacterial enzymes, particularly &#x3b1; subunits. AHSP may help stabilize the newly made &#x3b1; subunits until heme is available. The &#x3b2; subunits can stabilize themselves by self-associating to form relatively stable tetramers (see <figref idref="DRAWINGS">FIG. 1</figref>). However, in some cases further stabilization of the &#x3b2; subunits may be useful.</p>
<p id="p-0021" num="0020">Alpha hemoglobin stabilizing protein (AHSP), an 102 amino acid protein, expression may be induced by GATA-1, an essential erythroid transcription factor (Kihm, A J. et al. (2002) <i>Nature </i>417, 758-763). Expression of this protein may progressively increase during normal human erythropoiesis to levels of &#x2dc;0.1 mM in pro-erythroblasts (dos Santos, C. O. et al. (2004) <i>Exp Hematol </i>32, 157-162). AHSP may bind isolated holo-&#x3b1; subunits reversibly with an association equilibrium constant equal to 10 &#x3bc;M<sup>&#x2212;1</sup>. Holo-&#x3b2; chains may readily displace &#x3b1; subunits from AHSP to form intact hemoglobin (Kihm, A J. et al. (2002) <i>Nature </i>417, 758-763; Santiveri, C. M. et al. (2004) <i>J Biol Chem</i>; Gell, D. et al. (2002) <i>J Biol Chem </i>277, 40602-40609) because the equilibrium constant for the formation of holo-&#x3b1;<sub>1</sub>&#x3b2;<sub>1 </sub>dimers is &#x2dc;60,000 times greater than that for formation of the AHSP-&#x3b1; chain complex. Furthermore, it has been shown that &#x201c;knocking out&#x201d; the AHSP gene causes formation of &#x3b1; globin aggregates and Heinze bodies in red cells from normal mice, and exacerbates these processes in animals with &#x3b2;-thalassemia. Oxidation of bound &#x3b1; chains leads to slow formation of a stable hemichrome (Gell, D. et al. (2002) <i>J Biol Chem </i>277, 40602-40609), and interaction of &#x3b1; apoglobin with AHSP induces partial folding of the hemoglobin subunit. Marden's group in Paris has recently confirmed Gell et al.'s observations and discovered that CO binding to &#x3b1; chain is altered by binding to AHSP (Baudin-Creuza, v. et al. (2004) <i>J Biol Chem</i>). Bycroft's group in Cambridge, U.K. has solved the NMR solution structure of AHSP (Santiveri, C. M. et al. (2004) <i>J Biol Chem</i>). The protein forms a remarkably stable 3-helix bundle with a surface that appears to mimic the &#x3b2; subunit portion of the &#x3b1;<sub>1</sub>&#x3b2;<sub>1 </sub>interface. The residues forming this surface on AHSP were determined directly in NMR experiments with the &#x3b1; subunit-AHSP complex.</p>
<p id="p-0022" num="0021">Possible functions of AHSP during hemoglobin assembly are shown in <figref idref="DRAWINGS">FIG. 2</figref>, which is based on the molecular genetic, functional, and structural work of Weiss, Mackay, Bycroft, and coworkers (Kihm, A J. et al. (2002) <i>Nature </i>417, 758-763; Santiveri, C. M. et al. (2004) <i>J Biol Chem</i>; and Gell, D. et al. (2002) <i>J Biol Chem </i>277, 40602-40609). The three-helical bundle structure was taken from Santiveri et al. (PDB 1w09, (Santiveri, C. M. et al. (2004) <i>J Biol Chem</i>)). Weiss and Mackay have speculated that the primary purpose of AHSP is to prevent toxic effects from excess &#x3b1; globin synthesis by binding the &#x3b1; subunits and forming a hemichrome that prevents hemin loss, formation of radical oxygen species, and precipitation (Kihm, A J. et al. (2002) <i>Nature </i>417, 758-763; Kong, Y. et al. (2004) <i>J Clin. Invest.</i>). AHSP may also act as a hemoglobin chaperone to facilitate the initial folding of &#x3b1; subunits and allow more efficient and rapid formation of either apo- or heme-containing &#x3b1;<sub>1</sub>&#x3b2;<sub>1 </sub>dimers (Kihm, A J. et al. (2002) <i>Nature </i>417, 758-763; Luzzatto, L. et al. (2002) <i>Nature </i>417, 703-705). Newly formed &#x3b2; subunits assemble into apo- or heme-containing &#x3b2;<sub>4 </sub>tetramers (McGovern, P. et al. (1976) <i>J Biol Chem </i>251, 7871-7879; Ip, S. H. et al. (1976) <i>Biochemistry </i>15, 654-660; O'Malley, S. M. et al. (1994) <i>J Protein Chem </i>13, 585-590) and appear to act as self-chaperones. AHSP, when used in accordance with example embodiments of the present disclosure, may greatly facilitate hemoglobin formation in <i>E. coli </i>(and other microorganisms) and increase production to levels that make recombinant hemoglobin a feasible commercial starting material for blood substitutes.</p>
<p id="p-0023" num="0022">The chaperon activity of AHSP may be tested by co-expressing it with rHb in <i>E. coli </i>(and other microorganisms) and measuring changes in holohemoglobin expression. The effects of variant AHSP proteins, particularly those with different interface binding, may be tested in a similar manner.</p>
<p id="p-0024" num="0023">The system for co-expression AHSP with &#x3b1; (and &#x3b2;) hemoglobin in <i>E. coli </i>(or other microorganisms) may be optimized by: (i) subcloning various forms of the AHSP gene; (ii) inserting the AHSP gene into high and low copy vectors to regulate the level of AHSP chaperone activity; (iii) changing the AHSP promoter to an alternative inducer system to allow pre-expression of the AHSP gene; and (iv) constructing a low copy number plasmid containing both AHSP and other helper genes under control of an alternative promoter that could be incorporated into the bacterial chromosome. When an appropriate system is located, the relevant set of genes may be incorporated into the <i>E. coli </i>chromosome (or that of other microorganisms) to create a modular heme protein expression strain. Similar steps may also be followed to optimize systems in other cells, tissues, or organisms, such as animal erythroid cells.</p>
<p id="p-0025" num="0024">Full-length human AHSP cDNA (GenBank AF147435) has been cloned into the glutathione S-transferase (GST) fusion vector pGEX-2T (Amersham Biosciences). This plasmid may be used in co-expression. The fusion protein may be expressed in <i>E. coli </i>BL21 cells and purified by affinity chromatography as described by Gell et al. (Gell, D. et al. (2002) <i>J Biol Chem </i>277, 40602-40609).</p>
<p id="p-0026" num="0025">rHb pSGE1702 (pHb0.0) and pGEX-2T (AHSP) vectors (Baxter) may be used to co-transform <i>E.coli </i>and the HbCO derivative spectrum assay may be used to look for enhanced holo-Hb production. Mackay and Gell have observed that &#x3b1; chains bind equally well to the GST fusion protein and cleaved AHSP, and this observation has been confirmed by Marden and co-workers (Baudin-Creuza, v. et al. (2004) <i>J Biol Chem</i>). The pHb0.0 and pGEX-2T vectors may be maintained in <i>E. coli </i>by growth on tetracycline and ampicillin, and both expression systems are induced by IPTG. And AHSP has been shown to promote &#x3b1; chain synthesis in COS cells (<figref idref="DRAWINGS">FIG. 3</figref>). Methods similar to those used by Baudin-Creuza et al. (Baudin-Creuza, v. et al. (2004) <i>J Biol Chem</i>) may also be employed.</p>
<p id="p-0027" num="0026">The pGET-2T version of the His-tag AHSP expression vector may be used for sub-cloning the AHSP gene (without the His-tag) into the PTARA T7 expression vector(Wycuff, D. R. and Matthews, K. S. Generation of an AraC-araBAD Promoter-Regulated T7 Expression System (2000) <i>Anal. Biochem. </i>277, 67-73). AHSP also may be subcloned into pBAD33 under control of the AraC protein/araBAD promoter system (Wycuff, D. R. et al. (2000) <i>Anal. Biochem. </i>277, 67-73). Thus, AHSP expression may be induced with arabinose and rHb with IPTG. In some example embodiments, both AHSP and a heme transport gene, for example, a hug gene from <i>P. shigelloides</i>, may be subcloned into pBAD33.</p>
<p id="p-0028" num="0027">Systems discussed above may be further optimized to balance the production of AHSP and this hemoglobin stabilization with the other metabolic needs of the cell, tissue, or animal, and the metabolic needs for hemoglobin production.</p>
<p id="p-0029" num="0028">Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the disclosure as defined by the following claims.</p>
<?DETDESC description="Detailed Description" end="tail"?>
</description>
<us-claim-statement>What is claimed is:</us-claim-statement>
<claims id="claims">
<claim id="CLM-00001" num="00001">
<claim-text>1. A method of producing a recombinant hemoglobin &#x3b1; subunit comprising co-expressing a nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit, a nucleic acid encoding a recombinant &#x3b1; hemoglobin stabilizing protein, and a recombinant heme transport gene product in an <i>Escherichia coli </i>or a non-<i>Escherichia coli </i>microorganism cell.</claim-text>
</claim>
<claim id="CLM-00002" num="00002">
<claim-text>2. A method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the recombinant hemoglobin &#x3b1; subunit is a human recombinant hemoglobin &#x3b1; subunit and the recombinant &#x3b1; hemoglobin stabilizing protein is a human recombinant &#x3b1; hemoglobin stabilizing protein.</claim-text>
</claim>
<claim id="CLM-00003" num="00003">
<claim-text>3. A method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the nucleic acid encoding the &#x3b1; hemoglobin stabilizing protein is located in a plasmid.</claim-text>
</claim>
<claim id="CLM-00004" num="00004">
<claim-text>4. A method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit is located in a plasmid.</claim-text>
</claim>
<claim id="CLM-00005" num="00005">
<claim-text>5. A method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the nucleic acid encoding the heme transport gene product is located in a plasmid.</claim-text>
</claim>
<claim id="CLM-00006" num="00006">
<claim-text>6. A method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein, the recombinant hemoglobin &#x3b1; subunit, and the recombinant heme transport gene product are located in a single plasmid.</claim-text>
</claim>
<claim id="CLM-00007" num="00007">
<claim-text>7. A recombinant hemoglobin &#x3b1; subunit production cell comprising:
<claim-text>a nucleic acid encoding a recombinant hemoglobin &#x3b1; subunit;</claim-text>
<claim-text>a nucleic acid encoding a recombinant &#x3b1; hemoglobin stabilizing protein; and</claim-text>
<claim-text>a nucleic acid encoding a recombinant heme transport gene,</claim-text>
<claim-text>wherein the recombinant &#x3b1; hemoglobin stabilizing protein stabilizes the recombinant hemoglobin &#x3b1; subunit; and</claim-text>
<claim-text>wherein the cell is a <i>Escherichia coli </i>or a non-<i>Escherichia coli </i>microorganism cell.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00008" num="00008">
<claim-text>8. A cell according to <claim-ref idref="CLM-00007">claim 7</claim-ref>, wherein the recombinant hemoglobin &#x3b1; subunit is a human recombinant hemoglobin &#x3b1; subunit and the recombinant &#x3b1; hemoglobin stabilizing protein is a human recombinant &#x3b1; hemoglobin stabilizing protein.</claim-text>
</claim>
<claim id="CLM-00009" num="00009">
<claim-text>9. A cell according to <claim-ref idref="CLM-00007">claim 7</claim-ref> further comprising a plasmid comprising the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein.</claim-text>
</claim>
<claim id="CLM-00010" num="00010">
<claim-text>10. A cell according to <claim-ref idref="CLM-00007">claim 7</claim-ref>, further comprising a plasmid comprising the nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit.</claim-text>
</claim>
<claim id="CLM-00011" num="00011">
<claim-text>11. A cell according to <claim-ref idref="CLM-00007">claim 7</claim-ref>, further comprising a plasmid comprising the nucleic acid encoding the recombinant heme transport gene product.</claim-text>
</claim>
<claim id="CLM-00012" num="00012">
<claim-text>12. A cell according to <claim-ref idref="CLM-00007">claim 7</claim-ref>, further comprising a single plasmid comprising the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein, the recombinant hemoglobin &#x3b1; subunit, and the recombinant heme transport protein.</claim-text>
</claim>
<claim id="CLM-00013" num="00013">
<claim-text>13. A system for recombinant hemoglobin subunit production comprising:
<claim-text>an <i>Escherichia coli </i>or non-<i>Escherichia coli </i>microorganism production cell;</claim-text>
<claim-text>a nucleic acid encoding a recombinant hemoglobin &#x3b1; subunit;</claim-text>
<claim-text>a nucleic acid encoding an &#x3b1; hemoglobin stabilizing protein; and</claim-text>
<claim-text>a nucleic acid encoding a recombinant heme transport gene product,</claim-text>
<claim-text>wherein the nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit and the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein are co-expressed and the recombinant &#x3b1; hemoglobin stabilizing protein stabilizes at least one recombinant hemoglobin &#x3b1; subunit.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00014" num="00014">
<claim-text>14. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, wherein the recombinant hemoglobin &#x3b1; subunit is a human recombinant hemoglobin &#x3b1; subunit and the recombinant &#x3b1; hemoglobin stabilizing protein is a human recombinant &#x3b1; hemoglobin stabilizing protein.</claim-text>
</claim>
<claim id="CLM-00015" num="00015">
<claim-text>15. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, further comprising a plasmid comprising the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein.</claim-text>
</claim>
<claim id="CLM-00016" num="00016">
<claim-text>16. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, further comprising a plasmid comprising the nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit.</claim-text>
</claim>
<claim id="CLM-00017" num="00017">
<claim-text>17. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, further comprising a plasmid comprising the nucleic acid encoding the recombinant heme transport gene product.</claim-text>
</claim>
<claim id="CLM-00018" num="00018">
<claim-text>18. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, further comprising a single plasmid comprising the nucleic acid encoding the recombinant hemoglobin &#x3b1; subunit, the nucleic acid encoding the recombinant &#x3b1; hemoglobin stabilizing protein, and the nucleic acid encoding the recombinant heme transport gene product.</claim-text>
</claim>
<claim id="CLM-00019" num="00019">
<claim-text>19. The system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, further comprising a nucleic acid encoding a recombinant hemoglobin &#x3b2; subunit.</claim-text>
</claim>
<claim id="CLM-00020" num="00020">
<claim-text>20. A system according to <claim-ref idref="CLM-00013">claim 13</claim-ref>, wherein the system produces recombinant hemoglobin that may be used as part of a blood substitute product.</claim-text>
</claim>
</claims>
</us-patent-grant>
